No, the bolded bit is still wrong. The $117m net operating cash flow in the 2015 financial statements was the result after any GST payments had been subtracted.All I said is that those GST are to be paid, so the reported earnings or the net operating cash... that's not all $117m to be spent on whatever - $14m of it will be paid in GST... Further, I said they can delay and push it back, but it's not theirs, is it?
Honestly, I've never had any exposure to AHY in my portfolio at all.The obvious (and sincere) question I have to ask is why even bother with it ?
Honestly, I've never had any exposure to AHY in my portfolio at all.
My only real purpose here is correcting what I see as some pretty basic errors in another poster's analysis for the benefit of any one currently looking at the posts.
Probably a waste of half an hour, come to think of it...
Honestly, I've never had any exposure to AHY in my portfolio at all.
My only real purpose here is correcting what I see as some pretty basic errors in another poster's analysis for the benefit of any one currently looking at the posts.
Probably a waste of half an hour, come to think of it...
Honestly, I've never had any exposure to AHY in my portfolio at all.
My only real purpose here is correcting what I see as some pretty basic errors in another poster's analysis for the benefit of any one currently looking at the posts.
Probably a waste of half an hour, come to think of it...
Yes. I looked at it when it floated and tossed it aside after a couple of minutes. Haven't looked at it since. It's not going bust though.
No, the bolded bit is still wrong. The $117m net operating cash flow in the 2015 financial statements was the result after any GST payments had been subtracted.
If it's not included on there the cash movement for the period at the bottom of the Cash Flow Statement wouldn't match the movement of the bank account for the period on the balance sheet.So that $117m is after all GST that's due had been paid?
Show me.
I've read the CF statement and its note, don't see it.
Guys, a serious and genuine question.
I am not having a go, not criticising FA, not trying to start a who has the biggest to and fro series of comments etc.
I seriously admire the amount and depth of work that you guys put into these stocks.
This stock is now trading over 30 cents lower than it was two years ago, has paid 19.4 cents in dividends and only the last dividend was 50% franked.
The obvious (and sincere) question I have to ask is why even bother with it ?
If it's not included on there the cash movement for the period at the bottom of the Cash Flow Statement wouldn't match the movement of the bank account for the period on the balance sheet.
It's not like Asaleo are treating payments to the ATO for GST any differently than any other company.
Guys, a serious and genuine question.
I am not having a go, not criticising FA, not trying to start a who has the biggest to and fro series of comments etc.
I seriously admire the amount and depth of work that you guys put into these stocks.
This stock is now trading over 30 cents lower than it was two years ago, has paid 19.4 cents in dividends and only the last dividend was 50% franked.
The obvious (and sincere) question I have to ask is why even bother with it ?
No interest in the stock. Only interest here is making sure dribble is not misinterpreted as factual analysis. it's only Luutzu implying we're interested. Strawman stuff.
No interest in the stock. Only interest here is making sure dribble is not misinterpreted as factual analysis. it's only Luutzu implying we're interested. Strawman stuff.
A recovery on the cards for Asaleo Care? After spending four and a half months consolidating between 60c and 90c, AHY looks like it might be ready for a leg up. Today it has climbed 43.20% to 89.5c, reaching an intraday high of 96.2c on volume of around 8.7 million shares.
The catalyst for today's move north was this morning's announcement that AHY has sold its Australian Consumer Tissue business to Solaris Paper Pty Ltd. Under the terms of the transaction, Solaris Paper has agreed to pay Asaleo Care $180 million, resulting in a book profit on sale of between $15 - $20 million. The Australian Consumer Tissue business includes leading brands Sorbent toilet and facial tissue, Handee Ultra paper towel, and Deeko serviettes and disposable tableware.
The company claims that moving forward cash generation will be stronger as the Australian Consumer Tissue business has historically consumed approximately 30% of the AHY's capital spending. The market seems to like the deal and the fact that a lot of cash will now be at AHY's disposal.
It will be interesting to see if AHY can hold and consolidate above resistance at 90c.
View attachment 90650
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?